Recombinant MS4A1 (Rituximab Biosimilar) 抗体
This anti-MS4A1 (Rituximab Biosimilar) antibody is a Mammalian Cells 单克隆 antibody detecting MS4A1 (Rituximab Biosimilar) in ELISA. Suitable for 人.
Quick Overview for Recombinant MS4A1 (Rituximab Biosimilar) 抗体 (ABIN7487776)
抗原
MS4A1 (Rituximab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Mammalian Cells
克隆类型
单克隆
标记
This MS4A1 (Rituximab Biosimilar) antibody is un-conjugated
应用范围
ELISA
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Rituximab Biosimilar - Anti-MS4A1 mAb
-
产品特性
- Antibody Type: IgG1
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
亚型
- IgG1
-
-
anti-MS4A1 (Rituximab Biosimilar) antibody
适用: 人, Cynomolgus, 猕猴 FACS 宿主: 兔 Chimeric 10F381 unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS pH 7.5
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 4°C for short term, -20°C for long term
-
-
- MS4A1 (Rituximab Biosimilar)
-
物质类
- Biosimilar
-
背景
-
Rituximab
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells. When it binds to this protein it triggers cell death. Rituximab is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and EpsteinBarr virus-positive mucocutaneous ulcers.
抗原
-
You are here:
